iCAD to Report First Quarter 2022 Financial Results on Wednesday, May 11
NASHUA,
N.H. – April 27, 2022 – iCAD®, Inc. (NASDAQ:
ICAD), a global medical technology leader providing innovative cancer
detection and therapy solutions, today announced that it will release
financial results for the first quarter ended March 31, 2022, after the market
close, and host a conference call at 4:30 PM Eastern Time on Wednesday, May 11.
Wednesday, May 11th at 4:30 PM ET
Domestic: 888-506-0062
International: 973-528-0011
Conference
ID: 728427
Webcast: https://www.webcaster4.com/Webcast/Page/2879/45416
About iCAD, Inc.
Headquartered
in Nashua, NH, iCAD is a global medical technology leader providing innovative
cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media
Inquiries:
Jessica
Burns, iCAD
+1-201-423-4492
Investor
Inquiries:
iCAD
Investor Relations